Background: Hypoglycaemia-insulin test (HIT) is the ‘gold standard’ for the diagnosis of adrenal–pituitary–hypothalamic axis disorders. Controversy exists on the convenience of recovery from an insulin-induced hypoglycaemia since this test is not risk-free. Objective: To ascertain whether recovery from insulin-induced hypoglycaemia with an oral glucose solution produces a different response of growth hormone (GH) and cortisol at different times of the study compared with spontaneous recovery from hypoglycaemia. Patients and Methods: Prospective study of 100 children and adolescents with growth delay who underwent an HIT. Patients were consecutively assigned to two groups of 50. In one group recovery from hypoglycaemia occurred spontaneously and in the other recovery was achieved with an oral glucose solution (20 g of glucose) when glycaemia was under 30 mg/dl. The two groups did not differ in age, sex, pubertal status, weight, height and IGF-I levels. Results: The response of GH at 30, 60, 90 and 120 min and cortisol at 10, 60, 90 and 120 min was lower and statistically significant in patients with recovery from hypoglycaemia with oral glucose solution. GH deficiency was diagnosed more frequently in patients recovered with glucose solutions (94%) compared to those with spontaneous recovery (68%). Conclu sions: Oral glucose solution administration when glycaemia was under 30 mg/dl in HIT produced a lower GH and cortisol response to insulin stimulus and a greater frequency of GH deficit diagnosis.

1.
Shah A, Stanhope R, Matthew D: Hazards of pharmacological tests of growth hormone secretion in childhood. BMJ 1992;304:173–174.
2.
Ranke MB: Diagnosis of growth hormone deficiency and growth hormone stimulation tests; in Ranke MB (ed): Diagnostics of Endocrine Function in Children and Adolescents, ed 3. Basel, Karger, 2003, pp 107–128.
3.
Galloway PJ, McNeill E, Paterson WF, Donaldson MD: Safety of the insulin tolerance test. Arch Dis Child 2002;87:354–356.
4.
Borm K, Slawick M, Beuschlein F, Seiler L, Flohr F, Berg A, Koenig A, Reincke M: Low-dose glucose infusion after achieving critical hypoglycaemia during insulin tolerance testing: effects on time of hypoglycaemia, neuroendocrine stress response and patient’s discomfort in a pilot study. Eur J Endocrinol 2005;153:521–526.
5.
Page MD, Koppeschaar HP, Edwards CA, Dieguez C, Scanlon MF: Additive effects of growth hormone releasing factor and insulin hypoglycaemia on growth hormone release in man. Clin Endocrinol (Oxf) 1987;26:589–595.
6.
Hindmarsh PC, Brook CG: Short stature and growth hormone deficiency. Clin Endocrinol 1995;43:133–142.
7.
Hussain K, Hindmarsh P, Aynsley-Green A: Spontaneous hypoglycemia in childhood is accompanied by paradoxically low serum growth hormone and appropriate cortisol counter regulatory hormonal responses. J Clin Endocrinol Metab 2003;88:3715–3723.
8.
West TE, Sonksen PH: Is the growth-hormone response to insulin due to hypoglycaemia, hyperinsulinaemia or a fall in plasma free fatty acids? Clin Endocrinol (Oxf) 1977;7:283–288.
9.
Page MD, Koppeschaar HP, Edwards CA, Dieguez C, Scanlon MF: Additive effects of growth hormone releasing factor and insulin hypoglycaemia on growth hormone release in man. Clin Endocrinol (Oxf) 1987;26:589–595.
10.
Berelowitz M, Dudlak D, Frohman LA: Release of somatostatin-like immunoreactivity from incubated rat hypothalamus and cerebral cortex. Effects of glucose and glucoregulatory hormones. J Clin Invest 1982;69:1293–1301.
11.
Broglio F, Gottero C, Prodam F, Destefanis S, Gauna C, Me E, Riganti F, Vivenza D, Rapa A, Martina V, Arvat E, Bona G, van der Lely AJ, Ghigo E: Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans. Clin Endocrinol (Oxf) 2004;61:503–509.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.